𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Terminal antisense oligonucleotide modifications can enhance induced exon skipping

✍ Scribed by Bijanka L. Gebski; Stephen J. Errington; Russell D. Johnsen; Susan Fletcher; Stephen D. Wilton

Book ID
116792347
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
280 KB
Volume
15
Category
Article
ISSN
0960-8966

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Target selection for antisense oligonucl
Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene
✍ Stephen J. Errington; Christopher J. Mann; Sue Fletcher; Dr Stephen D. Wilton πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 308 KB

## Abstract ## Background Duchenne muscular dystrophy (DMD) is an X‐linked recessive muscle wasting disorder characterised by the absence of the protein dystrophin. Antisense oligonucleotides have been used to re‐direct dystrophin pre‐mRNA processing by blocking sequences crucial to pre‐mRNA splic

Improved antisense oligonucleotide induc
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
✍ Christopher J. Mann; Kaite Honeyman; Graham McClorey; Sue Fletcher; Stephen D. W πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 299 KB

## Abstract ## Background Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by dystrophin gene mutations that preclude synthesis of a functional protein. One potential treatment of the disorder has utilised antisense oligoribonucleotides (AOs) to induce removal of disease‐associ